Gene-Silencing Screen for Mammalian Axon Regeneration Identifies Inpp5f (Sac2) as an Endogenous Suppressor of Repair

Yixiao Zou1, Massimiliano Stagi1, Xingxing Wang1

  • 1Cellular Neuroscience, Neurodegeneration and Repair Program, Interdepartmental Neuroscience Program, Departments of Neurology and Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06536.

Insights

Gene silencing of Inpp5f (Sac2) promotes significant axon regeneration and functional recovery after spinal cord injury in mice. This discovery offers new therapeutic avenues for central nervous system repair.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Functional recovery after spinal cord injury (SCI) depends on axonal growth and neuronal rewiring.
  • Current interventions for promoting neural repair after SCI have limited functional efficacy.
  • Identifying endogenous suppressors of central nervous system (CNS) axon regeneration is crucial for developing effective therapies.

Purpose of the Study:

  • To identify novel genetic determinants that regulate mammalian CNS axon regeneration after injury.
  • To investigate the role of the phosphatase Inpp5f (Sac2) in suppressing CNS axon growth and repair.

Main Methods:

  • Conducted an unbiased RNAi gene-silencing screen across most phosphatases in the genome to identify suppressors of CNS axon growth.
  • Validated findings using cultured Inpp5f knockout (Inpp5f(-/-)) neurons and lentiviral shRNA.
  • Assessed anatomical and functional recovery in Inpp5f(-/-) mice after a mid-thoracic dorsal hemisection SCI model.

Main Results:

  • Identified 17 novel phosphatase suppressors of injury-induced CNS axon growth, including Inpp5f (Sac2).
  • Silencing Inpp5f led to robust enhancement of axon regeneration and growth cone reformation.
  • Inpp5f(-/-) mice exhibited enhanced sprouting of serotonergic and corticospinal tract axons, and improved motor function recovery post-SCI, independent of the PI3K/AKT/mTOR pathway.

Conclusions:

  • Inpp5f (Sac2) is a novel endogenous suppressor of CNS axon repair after SCI.
  • Gene deletion of Inpp5f promotes significant anatomical and functional recovery from SCI without apparent side effects.
  • The screening methodology can be applied genome-wide to discover genes involved in axonal regeneration, offering new therapeutic targets.